Micron’s Washington Play and the AI Memory Squeeze: A Two-Pronged Strategy

Micron's HBM capacity is sold out through 2026, while it pushes the MATCH Act to curb Chinese rivals. Stock hits €445.25 high with strong buy ratings.

Micron Technology is executing on two fronts simultaneously — one in the halls of Congress, the other on the factory floor. The US memory chip maker is lobbying hard for the MATCH Act, legislation that would tighten export controls on semiconductor equipment bound for China, while its production lines for high-bandwidth memory (HBM) are already sold out through the end of 2026. The combination has sent the stock soaring 57% over the past 30 days, with shares touching a fresh 52-week high of €445.25 on Monday.

The MATCH Act targets a specific loophole in the current regulatory framework. US companies already face strict export restrictions on chipmaking tools, but foreign suppliers have not been held to the same standard. The proposed law would force international equipment makers to comply with the same rules as their American counterparts. A House committee is currently reviewing the bipartisan bill, which would impose a nationwide ban on so-called key tools — the machines without which modern chips cannot be manufactured. Exceptions would apply only to facilities under US or allied control.

The legislation has a clear target list: Chinese chip factories operated by ChangXin Memory Technologies, Hua Hong, Huawei, SMIC, and Yangtze Memory Technologies. For Micron, the strategic logic is obvious. As the only US memory chip maker operating at meaningful scale, it stands to benefit directly. Less equipment reaching Chinese rivals means slower growth in China’s memory capacity, buying Micron time and market share.

The timing is no coincidence. The AI boom has created insatiable demand for HBM, the specialized memory that powers AI accelerators. Micron has confirmed that its entire HBM production capacity is booked through the end of 2026. That supply crunch is driving earnings expectations through the roof. In the most recent quarter, revenue nearly tripled to $23.86 billion, while earnings per share surged from $1.41 to $12.07. A key driver: NAND prices jumped 75% quarter-over-quarter at the start of 2026.

Wall Street has responded with a chorus of price target upgrades. The consensus rating remains “Strong Buy,” with Melius Research initiating coverage at $700, Stifel at $550, and Susquehanna at $525. The stock now trades at a price-to-earnings ratio of roughly 25, supported by exploding revenue. Analysts expect full-year earnings of $57.71 per share.

Away from the analyst community, options market activity has caught traders’ attention. Put option volume at the $510 strike price has surged to 90 times the normal level, suggesting large institutional investors are hedging their positions.

The political calculus remains uncertain. The House committee has not yet voted on the MATCH Act. If the bill fails, competitive pressure from Chinese manufacturers will persist. If it passes, it could set a precedent for future US technology export rules with far-reaching implications for the entire semiconductor industry.

Micron reports third-quarter results on July 1. Analysts expect earnings of nearly $19 per share, a tenfold increase from the prior year. The medium-term outlook remains driven by AI investment, though a cyclical risk lingers: if big tech companies scale back their data center spending, revenue could see a meaningful decline from 2028 onward. For now, Micron is playing both the political and production cards — and investors are buying the story.